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To report 2 patients with anti–myelin oligodendrocyte glycoprotein (MOG)-associated en-
cephalitis who were initially misdiagnosed with small vessel primary CNS vasculitis.
Methods
Review of symptoms, MRI and neuropathologic features, and response to treatment. MOG
antibodies were determined in serum and CSF using a cell-based assay.
Results
Symptoms included fever, headache, and progressive mental status changes and focal neuro-
logic deficits. CSF studies revealed lymphocytic pleocytosis, and both patients had abnormal
brain MRIs. Brain biopsy samples showed prominent lymphocytic infiltration of the wall of
small vessels; these findings initially suggested small vessel CNS vasculitis, and both patients
were treated accordingly. Although 1 patient had a relapsing-remitting course not responsive to
cyclophosphamide, the other one (also treated with cyclophosphamide) did not relapse.
Retrospective assessment of serum and CSF demonstrated MOG antibodies in both cases, and
review of biopsy specimens showed absence of fibrinoid necrosis (a pathologic requirement for
small vessel CNS vasculitis).
Conclusions
Anti–MOG-associated encephalitis can be mistaken for small vessel CNS vasculitis. This is
important because the diagnosis of anti–MOG-associated encephalitis does not require brain
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The diagnosis of small vessel primary CNS vasculitis is
challenging because conventional and brain MRI angiog-
raphy are negative, and brain biopsy remains as the only
definite diagnostic test.1 However, brain biopsy is invasive
and may be uninformative because of sampling error. Here,
we describe 2 patients with myelin oligodendrocyte gly-
coprotein (MOG) antibody–associated encephalitis2 who
were initially misdiagnosed with small vessel CNS vascu-
litis based on biopsy findings. Physicians should be aware of
this potential misdiagnosis because it has important clinical
implications.
Case 1
A 5-year-old boy presented with 2 weeks of frontal headache
and fever. His physical examination showed decreased
alertness and bilateral papilledema (table). Brain CT and
MRI (figure 1A) were normal, and the CSF showed pleo-
cytosis. Meningoencephalitis was suspected, and he was
started on steroids and acyclovir. During the following days,
he developed visual hallucinations. There was gradual clin-
ical improvement until complete recovery, and the patient
was discharged on steroid taper 1 month later. In the en-
suing 4 months, he was readmitted 3 times for relapsing
symptoms while weaning from steroids. Repeat brain MRI
showed T2 abnormalities in the basal ganglia, cerebellar
peduncles, and supratentorial white matter (figure 1B-D),
and CSF pleocytosis was identified in all episodes (table).
All relapses substantially improved after treatment with
steroids. At the last relapse, a conventional brain angiogra-
phy was inconclusive. Brain biopsy showed infiltrates
of lymphocytes involving the wall of small vessels and per-
ivascular areas accompanied by perivascular demyelination
(figure 2A–D). The patient was diagnosed with primary
CNS vasculitis, and he was started on monthly pulses of
cyclophosphamide. After the 5th pulse, he developed acute
right optic neuritis that was treated with steroids, resulting in
little improvement. Extensive blood testing identified an
elevation of lipoprotein A (also present in his asymptomatic
father), and oral aspirin was added, together with myco-
phenolate mofetil (MMF) and prednisone. He remained
clinically and radiologically stable (figure 1E), with a right
eye visual deficit for 2 years; at this time, immunosuppres-
sion was weaned, and shortly after stopping the steroids
(while on MMF and aspirin), he developed confusion and
decreased level of consciousness. MRI showed extensive
white matter abnormalities (figure 1F) and high serum titer
of MOG antibodies (1:640). Retrospective assessment of
stored serum and CSF obtained at onset of the disease were
also positive for MOG antibodies (serum titer 1:20,480 and
CSF 1:320, table). Review of the paraffin block containing
the brain biopsy showed that the inflammatory infiltrates
were not confined to the vessel wall and also involved the
white and gray matter. With these findings, the patient was
diagnosed with anti-MOG encephalitis, and treatment with
rituximab, azathioprine, and low-dose prednisone was initi-
ated. No more relapses were observed; at the last follow-up,
3 years later, he remained clinically and radiologically stable
on azathioprine and low-dose prednisone (eventually dis-
continued), and the serum titer of MOG immunoglobulin
G (IgG) antibodies had decreased (1:80) below the con-
sensus limit of positivity (≥1:160).2,3
Case 2
A 39-year-old woman with a history of ulcerative colitis
treated with mesalamine and budesonide developed severe,
progressive left temporo-parietal headache associated with
nausea and photophobia. Shortly after neurologic symptom
onset, she developed intermittent fever. Peripheral leukocy-
tosis with neutrophilic predominance and elevated C-reactive
protein were identified (table). Brain MRI showed hyperin-
tense gyriform fluid-attenuated inversion recovery signal over
the left temporal, parietal, and occipital lobes (figure 1G–H).
CSF analysis showed pleocytosis and elevated protein con-
centration, and the patient was started on empiric antibiotics
and acyclovir. Six days later, she developed expressive aphasia,
confusion, and agitation, and bilateral VI cranial nerve palsies.
Repeat brain MRI showed no changes, and CT angiography
demonstrated no clear evidence of vasculitis. A biopsy of the
left parietal lobe and dura showed interstitial and perivascular
lymphocytic infiltrates with marked involvement of the vessel
wall (figure 2E–H). There was no clear evidence of de-
myelination (data not shown). These findings led to suspect
CNS vasculitis, and high-dose IV steroids and oral cyclophos-
phamide were started. Four months later, cyclophosphamide
was discontinued because of elevated transaminases. The dose
of prednisone was tapered over the course of 2 years. During
the follow-up, the brain MRI normalized at 4 months and the
neurologic examination at 9 months; her only complaints were
mild aphasia when tired and chronic daily headache. Retro-
spective analysis of stored CSF obtained by the time of
symptom onset showed MOG-IgG antibodies (1:8).
Discussion
We describe 2 patients initially diagnosed with small vessel
CNS vasculitis but who in fact had anti–MOG-associated
encephalitis. The first patient received standard treatment for
CNS vasculitis, including cyclophosphamide and steroid-
sparing drugs. Although this treatment led to initial stabili-
zation of symptoms, the patient developed new relapses until
Glossary
MMF = mycophenolate mofetil; MOG = myelin oligodendrocyte glycoprotein.
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Table Clinical and laboratory data of 2 patients with anti-MOG encephalitis initially misdiagnosed with small CNS vessel vasculitis
Patient 1 Patient 2
Age, sex 5 years, male 39 years, female
Previous history None Ulcerative colitis
Attack 1 2 3 4 5 6 1





Headache and LGF Headache, blurry
vision, unsteady gait,
and DLC
LGF, right leg paresis,
hallucinations, and DLC
Pain, severe loss of
vision on the right eye,
and papilledema









Normal CRP and ESR Normal CRP, ESR, and
ferritin
Normal CRP and ESR Normal CRP, ESR,
elevation of lipoprotein A,a
and elevated vWF (150%)b
n.d. Normal CRP, ESR, and vWF Mildly elevated CRP
(3.62 mg/dL) and
normal ferritin
CSF studies 1st d; 4th d 1st d; 7th d; 8th d
WBC (cell/mm3) 50; 5 40 10 30 n.d. 5 64; 146; 112
Protein (mg/dL) 31; 26 54 50 68 n.d. 29 49; 65; 98
Neopterin (nmol/L)
(NR 9–55)




n.d.; positive (1: 320) Positive (1:20480); n.d. n.d.; n.d. n.d.; n.d. Positive (1:2,560); n.d. Positive (1:640); n.d. n.d.; positive (1:8)
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he was transitioned to a B-cell depletion therapy with good
clinical and serologic response. In the second patient, the
finding of MOG antibodies did not change the treatment
strategy because she was already clinically stable; however, an
earlier detection of these antibodies could have prevented the
brain biopsy.
In retrospect, none of these patients fulfilled the criteria for
small vessel CNS vasculitis. Although the presence of in-
flammatory cells in the vessel walls is sufficient to diagnose
medium or large vessel vasculitis, signs of vessel damage such
as fibrin deposition and/or necrosis (absent in our patients)
must also be present to meet the criteria for small vessel
vasculitis. Diapedesis of leukocytes takes place in small ves-
sels, and the presence of inflammatory cells in the walls does
not necessarily imply a pathologic process. Moreover, the
pathology of CNS vasculitis is usually focal or segmental,
and the brain biopsy specimen can be negative or not meet
the full diagnostic criteria.4 As our patients reveal, the pres-
ence of lymphoid cells in vessel walls must be interpreted
with caution, particularly when the differential diagnosis
includes encephalitis with lymphocytic infiltrates. In this
context, the presence of lymphocytes in the brain paren-
chyma away from the vessel walls favors secondary in-
volvement of the vessels rather than a primary vasculitic
process. Whether other cases of anti-MOG encephalitis
may have been misdiagnosed as CNS vasculitis is unknown.
There are reports of patients diagnosed with CNS small
vessel vasculitis by brain biopsy who later developed my-
elitis or optic neuritis5 (symptoms suggestive of MOG
encephalitis),2,3 making us to postulate that this misdiagnosis
may not be unusual.
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Figure 1 MRI of 2 patients with anti-MOG encephalitis initially misdiagnosed with small vessel CNS vasculitis
Patient 1: (A) Axial T2MRI sequence showing no abnormalities at disease onset; (B) bilateral involvement of the basal ganglia 4weeks after disease onset while
steroids were being decreased; (C) left cerebral peduncle abnormality at 6-week follow-up; (D) asymmetric large hazy white matter and basal ganglia lesions
at 4months; (E) residual white matter lesions and enlargement of ventricles due to brain atrophy; and (F) new asymmetric large hazy white matter lesions 30
months after disease onset when steroids were discontinued. Patient 2: (G and H) Axial FLAIR sequences showing gyriform hyperintensities with edema
similar to abnormalities previously reported in cases of anti–MOG-associated cortical encephalitis.6
Figure 2 Brain biopsy of 2 patients with anti-MOG encephalitis initially misdiagnosed with small vessel CNS vasculitis
In patient 1, biopsy of the right temporal lobe showed small vessel perivascular lymphocytic infiltration (A, hematoxylin-eosin staining; B, magnification of the
vessel shown in panel A). Inflammatory infiltrates included T and B lymphocytes (not shown) in association with edema, perivascular demyelination, and
reactive gliosis (C andD, luxol fast blue staining). In patient 2, biopsy of the left temporal lobe showedmarked perivascular lymphocytic infiltrates involving the
vessel wall (E, hematoxylin-eosin staining). The infiltrates were also composed of T lymphocytes (F, CD3 immunostaining), B lymphocytes (G, CD20 immu-
nostaining), andmacrophages (H, anti-CD68 immunostaining).Myelin staining did not show clear evidence of demyelination (not shown). Nonecrosis or fibrin
deposition was identified (not shown). Scale bar 200 μm in A and C, 500 μm in E, and 100 μm in B, D, and F–H.
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